# Freedom Holding Corp.: financial statements, quarterly

FRHC · Nasdaq · CIK 924805 · [Financials](/sectors/financials.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/frhc.md) · [Financials](/companies/frhc/financials.md) · [Filings](/companies/frhc/filings.md) · [Insiders](/companies/frhc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/frhc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [436](/filings/0000924805-24-000068.md) | [419](/filings/0000924805-25-000002.md) | [477 d](/filings/0000924805-26-000012.md) | [455](/filings/0000924805-25-000031.md) | [586](/filings/0000924805-25-000041.md) | [665](/filings/0000924805-26-000006.md) | [298 d](/filings/0000924805-26-000012.md) | [524](/filings/0000924805-26-000047.md) | [526](/filings/0000924805-25-000041.md) | [629](/filings/0000924805-26-000006.md) | [503 d](/filings/0000924805-26-000012.md) | [733](/filings/0000924805-26-000047.md) |
| Cost of revenue | $m | not reported | not reported | not reported | [4.3](/filings/0000924805-25-000031.md) | [5.2](/filings/0000924805-25-000041.md) | [9.4](/filings/0000924805-26-000006.md) | [12.4 d](/filings/0000924805-26-000012.md) | [13.9](/filings/0000924805-26-000047.md) | [15.1](/filings/0000924805-25-000041.md) | [25.3](/filings/0000924805-26-000006.md) | [25.2 d](/filings/0000924805-26-000012.md) | [35.2](/filings/0000924805-26-000047.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [139](/filings/0000924805-24-000068.md) | [131](/filings/0000924805-25-000002.md) | [135 d](/filings/0000924805-24-000041.md) | [146](/filings/0000924805-24-000060.md) | [125](/filings/0000924805-24-000068.md) | [131](/filings/0000924805-25-000002.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [19.2](/filings/0000924805-24-000068.md) | [15.5](/filings/0000924805-25-000002.md) | [9.0 d](/filings/0000924805-26-000012.md) | [7.3](/filings/0000924805-25-000031.md) | [14.0](/filings/0000924805-25-000041.md) | [20.2](/filings/0000924805-26-000006.md) | [(13.1) d](/filings/0000924805-26-000012.md) | [10.1](/filings/0000924805-26-000047.md) | [21.8](/filings/0000924805-25-000041.md) | [17.7](/filings/0000924805-26-000006.md) | [23.0 d](/filings/0000924805-26-000012.md) | [9.2](/filings/0000924805-26-000047.md) |
| Net income | $m | [116](/filings/0000924805-24-000068.md) | [96.4](/filings/0000924805-25-000002.md) | [98.8 d](/filings/0000924805-26-000012.md) | [34.4](/filings/0000924805-25-000031.md) | [115](/filings/0000924805-25-000041.md) | [78.3](/filings/0000924805-26-000006.md) | [(151) d](/filings/0000924805-26-000012.md) | [37.4](/filings/0000924805-26-000047.md) | [38.7](/filings/0000924805-25-000041.md) | [76.2](/filings/0000924805-26-000006.md) | [8.0 d](/filings/0000924805-26-000012.md) | [31.7](/filings/0000924805-26-000047.md) |
| Diluted EPS | $ per share | [1.95](/filings/0000924805-24-000068.md) | [1.63](/filings/0000924805-25-000002.md) | not reported | [0.57](/filings/0000924805-25-000031.md) | [1.89](/filings/0000924805-25-000041.md) | [1.29](/filings/0000924805-26-000006.md) | not reported | [0.61](/filings/0000924805-26-000047.md) | [0.63](/filings/0000924805-25-000041.md) | [1.25](/filings/0000924805-26-000006.md) | not reported | [0.52](/filings/0000924805-26-000047.md) |
| Basic EPS | $ per share | [1.97](/filings/0000924805-24-000068.md) | [1.65](/filings/0000924805-25-000002.md) | not reported | [0.58](/filings/0000924805-25-000031.md) | [1.93](/filings/0000924805-25-000041.md) | [1.32](/filings/0000924805-26-000006.md) | not reported | [0.62](/filings/0000924805-26-000047.md) | [0.65](/filings/0000924805-25-000041.md) | [1.27](/filings/0000924805-26-000006.md) | not reported | [0.52](/filings/0000924805-26-000047.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.5](/filings/0000924805-24-000068.md) | [0.6](/filings/0000924805-25-000002.md) | [0.5](/filings/0000924805-26-000012.md) | [0.7](/filings/0000924805-25-000031.md) | [0.6](/filings/0000924805-25-000041.md) | [0.6](/filings/0000924805-26-000006.md) | [0.8](/filings/0000924805-26-000012.md) | [0.6](/filings/0000924805-26-000047.md) | [0.6](/filings/0000924805-25-000041.md) | [0.9](/filings/0000924805-26-000006.md) | [1.0](/filings/0000924805-26-000047.md) | [1.4](/filings/0000924805-26-000047.md) |
| Current assets | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [7.1](/filings/0000924805-23-000114.md) | [7.4](/filings/0000924805-24-000014.md) | [8.3](/filings/0000924805-25-000012.md) | [8.5](/filings/0000924805-24-000060.md) | [8.8](/filings/0000924805-24-000068.md) | [9.1](/filings/0000924805-25-000002.md) | [9.9](/filings/0000924805-26-000012.md) | [9.7](/filings/0000924805-25-000031.md) | [10.3](/filings/0000924805-25-000041.md) | [12.4](/filings/0000924805-26-000006.md) | [13.2](/filings/0000924805-26-000047.md) | [14.0](/filings/0000924805-26-000047.md) |
| Current liabilities | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total liabilities | $bn | [6.2](/filings/0000924805-23-000114.md) | [6.4](/filings/0000924805-24-000014.md) | [7.1](/filings/0000924805-25-000012.md) | [7.3](/filings/0000924805-24-000060.md) | [7.6](/filings/0000924805-24-000068.md) | [7.9](/filings/0000924805-25-000002.md) | [8.7](/filings/0000924805-26-000012.md) | [8.5](/filings/0000924805-25-000031.md) | [9.1](/filings/0000924805-25-000041.md) | [11.0](/filings/0000924805-26-000006.md) | [11.7](/filings/0000924805-26-000047.md) | [12.5](/filings/0000924805-26-000047.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [0.9](/filings/0000924805-23-000114.md) | [1.0](/filings/0000924805-24-000014.md) | [1.2](/filings/0000924805-25-000012.md) | [1.1](/filings/0000924805-24-000060.md) | [1.3](/filings/0000924805-24-000068.md) | [1.3](/filings/0000924805-25-000002.md) | [1.2](/filings/0000924805-26-000012.md) | [1.2](/filings/0000924805-25-000031.md) | [1.2](/filings/0000924805-25-000041.md) | [1.4](/filings/0000924805-26-000006.md) | [1.5](/filings/0000924805-26-000047.md) | [1.5](/filings/0000924805-26-000047.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: not reported
- Total assets: us-gaap:Assets
- Current liabilities: not reported
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(438) d](/filings/0000924805-24-000068.md) | [(21.7) d](/filings/0000924805-25-000002.md) | [309 d](/filings/0000924805-26-000012.md) | [854](/filings/0000924805-25-000031.md) | [(438) d](/filings/0000924805-25-000041.md) | [(72.8) d](/filings/0000924805-26-000006.md) | [1,338 d](/filings/0000924805-26-000012.md) | [481](/filings/0000924805-26-000047.md) | [535 d](/filings/0000924805-25-000041.md) | [718 d](/filings/0000924805-26-000006.md) | [(1,549) d](/filings/0000924805-26-000012.md) | [(342)](/filings/0000924805-26-000047.md) |
| Capital expenditure | $m | [8.8 d](/filings/0000924805-24-000068.md) | [16.8 d](/filings/0000924805-25-000002.md) | [0.5 d](/filings/0000924805-26-000012.md) | [24.2](/filings/0000924805-25-000031.md) | [9.5 d](/filings/0000924805-25-000041.md) | [19.9 d](/filings/0000924805-26-000006.md) | [27.3 d](/filings/0000924805-26-000012.md) | [26.4](/filings/0000924805-26-000047.md) | [83.4 d](/filings/0000924805-25-000041.md) | [66.1 d](/filings/0000924805-26-000006.md) | [23.0 d](/filings/0000924805-26-000012.md) | [79.1](/filings/0000924805-26-000047.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q2 FY2023 (2022-09-30) | Q3 FY2023 (2022-12-31) | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | billions of shares | [59.5](/filings/0000924805-23-000114.md) | [59.5](/filings/0000924805-24-000014.md) | [59.3](/filings/0000924805-24-000060.md) | [59.3](/filings/0000924805-24-000068.md) | [0.1](/filings/0000924805-25-000002.md) | [0.1](/filings/0000924805-25-000031.md) | [0.1](/filings/0000924805-25-000041.md) | [0.1](/filings/0000924805-26-000006.md) | [0.1](/filings/0000924805-26-000047.md) | [0.1](/filings/0000924805-25-000041.md) | [0.1](/filings/0000924805-26-000006.md) | [0.1](/filings/0000924805-26-000047.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 63,787,666 at 2026-08-07, from the cover of the [10-Q filed 2026-08-10](/filings/0000924805-26-000047.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:29 ET. No prices; not investment advice.